MANAGEMENT OF PAEDIATRIC EPIPHORA AND ITS SUCCESS RATE IN A TERTIARY EYE CARE CENTER

Authors

  • SUDESHNA ROY Department of Ophthalmology, Nil Ratan Sircar Medical College and Hospital, Kolkata, West Bengal, India https://orcid.org/0009-0001-5439-5728
  • MITA SAHA DUTTA CHOWDHURY Department of Ophthalmology, College of Medicine and Sagore Dutta Hospital, Kolkata, West Bengal, India. https://orcid.org/0000-0002-9394-905X
  • DEBALINA GHANTA Department of Ophthalmology, Nil Ratan Sircar Medical College and Hospital, Kolkata, West Bengal, India https://orcid.org/0000-0002-5973-9227
  • KUSUM KUMARI PRASAD Tutor, Nil Ratan Sircar Medical College and Hospital, Kolkata, West Bengal, India. https://orcid.org/0009-0006-4129-1520

DOI:

https://doi.org/10.22159/ajpcr.2024v17i8.51404

Keywords:

Epiphora, Congenital nasolacrimal duct, Lacrimal sac massage, Probing, Intubation DCR

Abstract

Objectives: The objectives of the study are to assess the children under 5 years of age presenting with epiphora and to institute proper treatment with regular follow-up to get an overview of treatment success.

Methods: A prospective and non-randomized study was conducted on 518 eyes of 353 patients 165 (B/L) and 188 (U/L) that presented to us between April 2014 and April 2015. Informed consent was taken from parents. Institutional Ethical Committee approval was taken. The patients were followed up quarterly for 1st year to look for the resolution of signs and symptoms and if required quarterly till the resolution of the disease. Statistical analysis was done using Chi-square and Fisher’s exact test to test the difference in proportions. p<0.05 was denoted as statistically significant.

Result: Congenital nasolacrimal duct obstruction (NLDO) was the most common cause of childhood epiphora - 76% (394/518) followed by trauma (iatrogenic and non-iatrogenic) seen in 18% (93/518), acquired NLDO in 4% (21/518) and punctual causes 2% (10/518). The overall treatment success rate was 82%, individual success rate: Sac Massage: 85.9%, probing: 73.95%, dacryocystorhinostomy (DCR): 72%, punctum surgery: 100%. Although with increasing age, success rate of massage and probing reduced.

Conclusion: Sac massage is the best treatment in children till 1 year of age and probing is very effective till 3 years of age. Thus, early treatment prevents further chances of surgical intervention.

Downloads

Download data is not yet available.

References

Piest KL, Katowitz JA. Treatment of congenital nasolacrimal duct obstruction. Ophthalmol Clin North Am. 1991;4:201-9.

Guerry D 3rd, Kendig EL Jr. Congenital impatency of the nasolacrimal duct. Arch Ophthal. 1948;39(2):193-204. doi: 10.1001/ archopht.1948.00900020198006, PMID: 18868825

Duke-Elder S. System of Ophthalmology Embryology Part 1. Vol. 3. London: Henry Kimpton; 1963. p. 241-5.

Kipp MA, Allen RC. Congenital NLDO. Oculofacial Plastic Surgery Education Center. Available from: http://www.aao.org

Saleem AA. Congenital nasolacrimal duct obstruction and the visual system. In: Ziaei A, editor. Frontiers in Ophthalmology and Ocular Imaging. London: IntechOpen; 2019. doi: 10.5772/intechopen.82546

Casady DR, Meyer DR, Simon JW, Stasior GO, Zobal-Ratner JL. Stepwise treatment paradigm for congenital nasolacrimal duct obstruction. Ophthalmic Plast Reconstr Surg. 2006;22:243-7. doi: 10.1097/01.iop.0000225750.25592.7f, PMID: 16855492

Kumar DK, Dubey DA, Borasi DS, Som DV. Congenital dacryocystitis-clinical profile and outcome. Trop J Ophthalmol Otolaryngol. 2018;3(3):21-6. doi: 10.17511/jooo.2018.i03.03

Honovar SG, Prakash VE, Rao GN. Outcome of probing for congenital nasolacrimal duct obstruction in older children. Am J Ophthalmol. 2000;180:42-8.

MacEwen CJ, Young JD. Epiphora during the first year of life. Eye (Lond). 1991;5(Pt 5):596-600. doi: 10.1038/eye.1991.103, PMID: 1794426

Published

07-08-2024

How to Cite

SUDESHNA ROY, MITA SAHA DUTTA CHOWDHURY, DEBALINA GHANTA, and KUSUM KUMARI PRASAD. “MANAGEMENT OF PAEDIATRIC EPIPHORA AND ITS SUCCESS RATE IN A TERTIARY EYE CARE CENTER”. Asian Journal of Pharmaceutical and Clinical Research, vol. 17, no. 8, Aug. 2024, pp. 74-77, doi:10.22159/ajpcr.2024v17i8.51404.

Issue

Section

Original Article(s)